AUSTIN, Texas–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee. On January 31, 2024, the Compensation Committee of Savara’s Board of Directors granted the inducement awards to a new employee who recently joined the Company. The inducement awards consist of options to purchase 70,000 shares of the Company’s common stock and restricted stock units (RSUs) c
Business Wire Stock Sale/Buyback News
